• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

矿物粉尘诱导基因通过调节 EGFR 和 HIF-1α 信号通路来调节 VEGF-A/C/D 的表达,从而调控肺腺癌中的血管生成和淋巴管生成。

The mineral dust-induced gene, , regulates angiogenesis and lymphangiogenesis in lung adenocarcinoma by modulating the expression of VEGF-A/C/D via EGFR and HIF-1α signaling.

机构信息

Department of Pulmonary Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.

出版信息

Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8011. Epub 2021 Mar 24.

DOI:10.3892/or.2021.8011
PMID:33760153
Abstract

Mineral dust‑induced gene () is a novel lung cancer‑related oncogene. The aim of this study was to explore the effects of mdig on angiogenesis and lymphangiogenesis by vascular endothelial growth factor (VEGF) in lung adenocarcinoma. mdig‑overexpressing A549, H1299 and 293T cells, mdig‑silenced A549, human umbilical vein endothelial cells (HUVECs) and human lymphatic endothelial cells (HLECs) were cultured under normoxic and hypoxic conditions. Protein expression levels of mdig, epidermal growth factor receptor (EGFR), phospho(p)‑EGFR Tyr1068, hypoxia‑inducible factor‑1α (HIF‑1α), VEGF‑A/C/D and VEGF‑R1/R2/R3 were assessed using western blotting. mRNA expression levels of mdig, EGFR and HIF‑1α were measured using RT‑qPCR. Tube formation and xenograft tumor experiments were performed to examine the mechanism of mdig in angiogenesis and lymphangiogenesis. Protein expression levels of EGFR, HIF‑1α and VEGF‑A/C/D were significantly upregulated in cells cultured under hypoxic conditions compared with those cultured under normoxic conditions, whereas the levels of mdig were decreased. Protein expression levels of EGFR, p‑EGFR and VEGF‑A/R1/R2 were significantly increased in the mdig‑overexpressing cells, whereas the levels of HIF‑1α and VEGF‑C/D/R3 were decreased compared with those in control cells, all of which were reversed in mdig‑silenced cells. Tumor volumes and density of angiogenesis in the mdig‑overexpressing group were significantly increased compared with those in the control group, whereas the density of lymphangiogenesis was decreased. No tumors formed in the mdig‑silenced group after 3 weeks of assessment . Protein expression levels of EGFR, p‑EGFR, VEGF‑A and angiogenesis density were significantly reduced in the mdig‑overexpressing cells treated with an EGFR inhibitor, whereas the levels of HIF‑1α, VEGF‑C/D and the lymphangiogenesis density were significantly increased in mdig‑overexpressing cells treated with a HIF‑1α agonist. All changes in protein expression were reversed in EGFR agonist and HIF‑1α inhibitor treated mdig‑silenced cells. In conclusion, mdig is an oxygen‑sensitive protein that promotes tumor growth and angiogenesis by activating the EGFR/p‑EGFR/VEGF‑A/VEGF‑R1/R2 pathway and inhibits lymphangiogenesis by blocking the HIF‑1α/VEGF‑C/D/VEGF‑R3 pathway.

摘要

矿物尘埃诱导基因()是一种新的肺癌相关癌基因。本研究旨在探讨在肺腺癌中通过血管内皮生长因子(VEGF)介导的mdig 对血管生成和淋巴管生成的影响。在常氧和低氧条件下培养mdig 过表达的 A549、H1299 和 293T 细胞、mdig 沉默的 A549、人脐静脉内皮细胞(HUVECs)和人淋巴管内皮细胞(HLECs)。采用 Western blot 检测 mdig、表皮生长因子受体(EGFR)、磷酸化(p)-EGFR Tyr1068、缺氧诱导因子-1α(HIF-1α)、VEGF-A/C/D 和 VEGF-R1/R2/R3 的蛋白表达水平。采用 RT-qPCR 检测 mdig、EGFR 和 HIF-1α 的 mRNA 表达水平。进行管形成和异种移植肿瘤实验,以研究 mdig 在血管生成和淋巴管生成中的作用机制。与常氧条件下培养的细胞相比,低氧条件下培养的细胞中 mdig 的蛋白表达水平显著下调,而 EGFR、HIF-1α 和 VEGF-A/C/D 的蛋白表达水平显著上调。与对照组相比,mdig 过表达细胞中 EGFR、p-EGFR 和 VEGF-A/R1/R2 的蛋白表达水平显著增加,而 HIF-1α 和 VEGF-C/D/R3 的蛋白表达水平显著降低,这些变化在 mdig 沉默细胞中均被逆转。mdig 过表达组的肿瘤体积和血管生成密度明显高于对照组,而淋巴管生成密度则降低。在 3 周的评估后,mdig 沉默组没有形成肿瘤。在 mdig 过表达细胞中用 EGFR 抑制剂处理后,EGFR、p-EGFR、VEGF-A 和血管生成密度的蛋白表达水平显著降低,而在用 HIF-1α 激动剂处理的 mdig 过表达细胞中,HIF-1α、VEGF-C/D 和淋巴管生成密度的蛋白表达水平显著增加。在 EGFR 激动剂和 HIF-1α 抑制剂处理的 mdig 沉默细胞中,所有蛋白表达的变化均被逆转。总之,mdig 是一种氧敏感蛋白,通过激活 EGFR/p-EGFR/VEGF-A/VEGF-R1/R2 通路促进肿瘤生长和血管生成,通过阻断 HIF-1α/VEGF-C/D/VEGF-R3 通路抑制淋巴管生成。

相似文献

1
The mineral dust-induced gene, , regulates angiogenesis and lymphangiogenesis in lung adenocarcinoma by modulating the expression of VEGF-A/C/D via EGFR and HIF-1α signaling.矿物粉尘诱导基因通过调节 EGFR 和 HIF-1α 信号通路来调节 VEGF-A/C/D 的表达,从而调控肺腺癌中的血管生成和淋巴管生成。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8011. Epub 2021 Mar 24.
2
PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.PAR2 通过激活 EGFR 通路促进肺腺癌相关的血管生成。
Tissue Cell. 2022 Dec;79:101918. doi: 10.1016/j.tice.2022.101918. Epub 2022 Sep 6.
3
Hypoxia induces miR-153 through the IRE1α-XBP1 pathway to fine tune the HIF1α/VEGFA axis in breast cancer angiogenesis.缺氧通过 IRE1α-XBP1 通路诱导 miR-153 来精细调节乳腺癌血管生成中的 HIF1α/VEGFA 轴。
Oncogene. 2018 Apr;37(15):1961-1975. doi: 10.1038/s41388-017-0089-8. Epub 2018 Jan 25.
4
MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.微小 RNA-204 在肺腺癌中的失调通过调节 Janus 激酶 2-信号转导子和转录激活子 3 通路潜在地控制内皮细胞的生物学行为。
IUBMB Life. 2018 Jan;70(1):81-91. doi: 10.1002/iub.1706.
5
Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.新型低氧诱导因子抑制剂苯并吡喃基1,2,3-三唑化合物的分子及功能评估
Oncotarget. 2017 Jan 31;8(5):7801-7813. doi: 10.18632/oncotarget.13955.
6
TNF‑α inhibits xenograft tumor formation by A549 lung cancer cells in nude mice via the HIF‑1α/VASP signaling pathway.TNF-α 通过 HIF-1α/VASP 信号通路抑制裸鼠中 A549 肺癌细胞的异种移植肿瘤形成。
Oncol Rep. 2019 Apr;41(4):2418-2430. doi: 10.3892/or.2019.7026. Epub 2019 Feb 21.
7
Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.视网膜母细胞瘤结合蛋白2(RBP2)通过Akt途径促进HIF-1α-VEGF诱导的非小细胞肺癌血管生成。
PLoS One. 2014 Aug 27;9(8):e106032. doi: 10.1371/journal.pone.0106032. eCollection 2014.
8
Mdig promotes oncogenic gene expression through antagonizing repressive histone methylation markers.Mdig 通过拮抗抑制性组蛋白甲基化标记物促进致癌基因表达。
Theranostics. 2020 Jan 1;10(2):602-614. doi: 10.7150/thno.36220. eCollection 2020.
9
Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.缺氧诱导因子-1α/血管内皮生长因子信号激活与放疗反应相关,其抑制可减少肺癌缺氧诱导的血管生成。
J Cell Biochem. 2018 Sep;119(9):7707-7718. doi: 10.1002/jcb.27120. Epub 2018 Jun 15.
10
Activation of Epidermal Growth Factor Receptor/p38/Hypoxia-inducible Factor-1α Is Pivotal for Angiogenesis and Tumorigenesis of Malignantly Transformed Cells Induced by Hexavalent Chromium.表皮生长因子受体/p38/缺氧诱导因子-1α的激活对于六价铬诱导的恶性转化细胞的血管生成和肿瘤发生至关重要。
J Biol Chem. 2016 Jul 29;291(31):16271-81. doi: 10.1074/jbc.M116.715797. Epub 2016 May 25.

引用本文的文献

1
Deciphering the angiogenic potential of Zhishi Xiebai Guizhi decoction in coronary heart disease: an in-depth network pharmacology and experimental investigation.解析枳实薤白桂枝汤治疗冠心病的血管生成潜力:深入的网络药理学与实验研究
Sci Rep. 2025 Jul 2;15(1):23629. doi: 10.1038/s41598-025-05379-1.
2
Transcriptome analysis of the cytokine storm-related genes among the subtypes of idiopathic multicentric Castleman disease.特发性多中心Castleman病各亚型中细胞因子风暴相关基因的转录组分析
J Clin Exp Hematop. 2024 Dec 25;64(4):297-306. doi: 10.3960/jslrt.24061. Epub 2024 Oct 28.
3
Analysis of genomic alternations in epidermal growth factor receptor (EGFR)-T790M-mutated non-small cell lung cancer (NSCLC) patients with acquired resistance to osimertinib therapy.
对表皮生长因子受体(EGFR)-T790M突变的非小细胞肺癌(NSCLC)患者中对奥希替尼治疗产生获得性耐药的基因组改变的分析。
Clin Transl Oncol. 2025 May;27(5):1967-1979. doi: 10.1007/s12094-024-03727-7. Epub 2024 Sep 24.
4
Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors.血管内皮生长因子 A 的表达调控及在恶性肿瘤中的靶向治疗。
J Cancer Res Clin Oncol. 2024 Apr 30;150(5):221. doi: 10.1007/s00432-024-05714-5.
5
Advances in lymphatic metastasis of non-small cell lung cancer.非小细胞肺癌淋巴转移的研究进展。
Cell Commun Signal. 2024 Apr 2;22(1):201. doi: 10.1186/s12964-024-01574-1.
6
Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors.接受一线贝伐单抗联合第一代/第二代表皮生长因子受体酪氨酸激酶抑制剂治疗的晚期表皮生长因子受体突变型肺腺癌患者的序贯治疗
Front Oncol. 2023 Oct 3;13:1249106. doi: 10.3389/fonc.2023.1249106. eCollection 2023.
7
Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.阿法替尼治疗伴有主要非常见表皮生长因子受体(EGFR)突变(G719X/L861Q/S768I)的未经治疗的 IIIB/IV 期肺腺癌:来自台湾的一项多中心观察性研究。
Target Oncol. 2023 Mar;18(2):195-207. doi: 10.1007/s11523-023-00946-w. Epub 2023 Feb 20.
8
MDIG, a 2‑oxoglutarate‑dependent oxygenase, acts as an oncogene and predicts the prognosis of multiple types of cancer.MDIG,一种 2-氧戊二酸依赖性加氧酶,作为一种癌基因,可预测多种类型癌症的预后。
Int J Oncol. 2022 Jul;61(1). doi: 10.3892/ijo.2022.5372. Epub 2022 May 18.